9,10-dimethyl-1,2-benzanthracene and Angiogenesis, Pathologic

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cheek; Cricetinae; Disease Models, Animal; Humans; Mesocricetus; Mouth; Mouth Mucosa; Mouth Neoplasms; Neoplasm Transplantation; Neovascularization, Pathologic; Rabbits

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Apoptosis; Carcinogenesis; Cell Proliferation; Chemical and Drug Induced Liver Injury; Drug Compounding; Drugs, Chinese Herbal; Liver; Male; Mesocricetus; Mouth Neoplasms; Neovascularization, Pathologic; Oxidative Stress; Signal Transduction; Squamous Cell Carcinoma of Head and Neck

Topics: 9,10-Dimethyl-1,2-benzanthracene; Alkaloids; Angiogenesis Inhibitors; Animals; Apoptosis; Carcinoma, Squamous Cell; Caspase 3; Caspase 9; Cheek; Cricetinae; Indole Alkaloids; Male; Mesocricetus; Mouth Neoplasms; Neovascularization, Pathologic; Signal Transduction; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Arteries; Autoradiography; Blood Flow Velocity; Blood Volume; Blood Volume Determination; Female; Mammary Neoplasms, Experimental; Neovascularization, Pathologic; Perfusion Imaging; Pulmonary Circulation; Rats, Sprague-Dawley; Regional Blood Flow; Time Factors; Tumor Microenvironment; Veins

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Female; Imatinib Mesylate; Inflammation; Lipopolysaccharides; Lung Neoplasms; Neoplasm Proteins; Neoplasms, Experimental; Neovascularization, Pathologic; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley

Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Apoptosis; Blotting, Western; Cell Proliferation; Cetirizine; Drug Synergism; Female; Fibroblast Growth Factor 2; Mammary Neoplasms, Experimental; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Thalidomide; Vascular Endothelial Growth Factor A

Topics: 9,10-Dimethyl-1,2-benzanthracene; Activins; Animals; Carcinogens; Carcinoma, Squamous Cell; Chemotaxis; Female; Humans; Injections, Intralesional; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Neovascularization, Pathologic; Neutrophil Infiltration; Papilloma; Proto-Oncogene Proteins c-kit; Recombinant Proteins; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate; Wound Healing

Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Apoptosis; Carcinogens; Carcinoma, Squamous Cell; Cell Proliferation; Cell Transformation, Neoplastic; Cricetinae; Cyclin D1; Diterpenes; Immunoenzyme Techniques; Male; Mesocricetus; Mouth Mucosa; Mouth Neoplasms; Neoplasms, Experimental; Neovascularization, Pathologic; Proliferating Cell Nuclear Antigen; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Boron Compounds; Boron Neutron Capture Therapy; Carcinogens; Cricetinae; Mesocricetus; Mouth Neoplasms; Neovascularization, Pathologic; Phenylalanine; Precancerous Conditions; Thalidomide

Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Carcinogenesis; Cell Hypoxia; Cell Line; Cell Line, Tumor; Cheek; Ellagic Acid; Endothelial Cells; Histone Deacetylases; Male; Mesocricetus; Mitogen-Activated Protein Kinases; Molecular Docking Simulation; Neovascularization, Pathologic; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Biomarkers, Tumor; Carcinogens; Cell Proliferation; Cheek; Cricetinae; Disease Models, Animal; Endothelium, Vascular; Immunoenzyme Techniques; Mesocricetus; Mouth Neoplasms; Neovascularization, Pathologic; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Antigens, CD34; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Hormone Antagonists; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Methylnitrosourea; Mice; Mifepristone; Neovascularization, Pathologic; Norpregnadienes; Progesterone; Progestins; Rats; Receptors, Estrogen; Receptors, Progesterone; Time Factors

Topics: 9,10-Dimethyl-1,2-benzanthracene; Active Transport, Cell Nucleus; Animals; Benz(a)Anthracenes; Blueberry Plants; Carcinogens; Cell Line, Transformed; Dietary Supplements; Freeze Drying; Fruit; Gene Expression Regulation, Neoplastic; Humans; Male; Mesocricetus; Mouth Neoplasms; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms, Squamous Cell; Neovascularization, Pathologic; Random Allocation; Signal Transduction; Transcription Factor RelA; Transforming Growth Factor beta

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bone Morphogenetic Protein 2; Carcinoma, Squamous Cell; Cheek; Cricetinae; Humans; Male; Mesocricetus; Microvessels; Morphogenesis; Mouth Neoplasms; Neovascularization, Pathologic; Recombinant Proteins; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Biomarkers, Tumor; Body Weight; Carcinogenesis; Cell Proliferation; Cricetinae; Diosmin; Male; Mouth; Mouth Neoplasms; Neovascularization, Pathologic; Signal Transduction; STAT3 Transcription Factor

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antioxidants; Aryl Hydrocarbon Hydroxylases; Carcinogens; Cell Proliferation; Cricetinae; Cyclin D1; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; DNA Damage; Free Radical Scavengers; Lactoferrin; Male; Matrix Metalloproteinase 9; Mesocricetus; Mouth Neoplasms; Neovascularization, Pathologic; Oxidation-Reduction; Phenols; Proliferating Cell Nuclear Antigen; Random Allocation; Tissue Inhibitor of Metalloproteinase-2; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Carcinogens; Drug Resistance, Neoplasm; Female; Mammary Neoplasms, Animal; Medroxyprogesterone Acetate; Mutation; Neovascularization, Pathologic; Osteonectin; Pilot Projects; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A

Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Carcinogens; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Chemoprevention; Cricetinae; Male; Mesocricetus; Mouth Mucosa; Mouth Neoplasms; Neoplasms, Experimental; Neovascularization, Pathologic; Precancerous Conditions; RNA, Messenger; Thalidomide; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Carcinogens; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Female; Immunity, Cellular; Mice; Mice, Inbred C3H; Mice, Knockout; Neovascularization, Pathologic; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skin Neoplasms; Stilbenes; Toll-Like Receptor 4

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Tumor; Cell Proliferation; Cheek; Cricetinae; Cyclooxygenase 2; Dinoprostone; Male; Mesocricetus; Mouth Mucosa; Mouth Neoplasms; Neovascularization, Pathologic; Sulindac; Vascular Endothelial Growth Factor A

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antioxidants; Base Sequence; Cheek; Cricetinae; DNA Damage; DNA Primers; Enzymes; Free Radical Scavengers; In Vitro Techniques; Limonins; Male; Mesocricetus; Mouth Mucosa; Neoplasm Invasiveness; Neoplasms, Experimental; Neovascularization, Pathologic; Xenobiotics

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Female; Interferon-gamma; Interleukin-12; Interleukin-17; Interleukin-23; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neovascularization, Pathologic; T-Lymphocytes, Regulatory; Toll-Like Receptor 4; Transforming Growth Factor beta

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apigenin; Dose-Response Relationship, Drug; Female; Immunohistochemistry; Mammary Neoplasms, Animal; Medroxyprogesterone Acetate; Neovascularization, Pathologic; Placebos; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Cheek; Cricetinae; Cyclin D1; Diterpenes; Dose-Response Relationship, Drug; eIF-2 Kinase; Humans; I-kappa B Kinase; Mouth Neoplasms; Neovascularization, Pathologic; NF-kappa B; Phosphorylation; Proto-Oncogene Proteins c-myc

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Benzofurans; Carcinogens; Cricetinae; Drug Interactions; Flavonoids; Gas Chromatography-Mass Spectrometry; Histocytochemistry; Male; Mesocricetus; Metabolic Networks and Pathways; Metabolome; Metabolomics; Mouth Neoplasms; Neovascularization, Pathologic

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Carcinoma; Cell Movement; Cell Transformation, Neoplastic; Cytoskeleton; Disease Progression; Endothelial Cells; Focal Adhesion Protein-Tyrosine Kinases; Intracellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Neovascularization, Pathologic; Papilloma; Phorbols; Protein Serine-Threonine Kinases; Skin Neoplasms; Vascular Endothelial Growth Factor Receptor-2

Topics: 9,10-Dimethyl-1,2-benzanthracene; Acyclic Monoterpenes; Animals; Apoptosis; Biomarkers, Tumor; Carcinogens; Carcinoma, Squamous Cell; Cell Proliferation; Cell Transformation, Neoplastic; Cricetinae; Inflammation; Mesocricetus; Mouth Mucosa; Mouth Neoplasms; Neoplasms, Experimental; Neovascularization, Pathologic; Terpenes

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Atorvastatin; Cell Proliferation; Croton Oil; Epidermal Cells; Epidermis; Female; Heptanoic Acids; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mevalonic Acid; Mice; Neovascularization, Pathologic; Pyrroles; Rats; Rats, Wistar; Skin Neoplasms

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; beta Catenin; Blotting, Western; Cheek; Chlorophyllides; Cricetinae; Enzyme Activation; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Histone Deacetylases; Male; Mouth Neoplasms; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA, Messenger; Wnt Signaling Pathway

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Apoptosis; Carcinogens; Cell Division; Cricetinae; Curcumin; Male; Mesocricetus; Mouth Neoplasms; Neovascularization, Pathologic; Tea

Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Antibiotics, Antineoplastic; Carcinogens; Carcinoma in Situ; Carcinoma, Intraductal, Noninfiltrating; Cyclohexanes; Disease Models, Animal; Drug Interactions; Female; Mammary Neoplasms, Experimental; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Tamoxifen

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Division; Cell Line, Tumor; Exercise Test; Female; Inflammation; Lymphoma; Mice; Mice, Inbred BALB C; Necrosis; Neoplasm Transplantation; Neovascularization, Pathologic; Physical Conditioning, Animal; Rest

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Base Sequence; Carcinoma in Situ; DNA Primers; Female; Humans; Hyperplasia; Mammary Neoplasms, Experimental; Neovascularization, Pathologic; Piperidines; Quinazolines; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor Receptor-2

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Celecoxib; Cheek; Cricetinae; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Immunoenzyme Techniques; In Situ Nick-End Labeling; Isoenzymes; Male; Mesocricetus; Mouth Neoplasms; Neovascularization, Pathologic; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Cricetinae; Lymphangiogenesis; Male; Mesocricetus; Neoplasm Invasiveness; Neovascularization, Pathologic; Tongue Neoplasms; Vascular Endothelial Growth Factor C

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Carcinogens; Cell Transformation, Neoplastic; Cricetinae; Genistein; Male; Mesocricetus; Mouth Neoplasms; Neoplasms, Experimental; Neovascularization, Pathologic

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Carcinogens; Cell Growth Processes; Cell Transformation, Neoplastic; Cyclic AMP; Dinoprostone; Drug Eruptions; Female; Hyperplasia; Keratinocytes; Mice; Mice, Knockout; Neovascularization, Pathologic; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP3 Subtype; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate

Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Animals; Benzofurans; Carcinogens; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Chemoprevention; Cricetinae; Male; Mesocricetus; Mouth Neoplasms; Neovascularization, Pathologic; Precancerous Conditions; Random Allocation

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Implants; Immunohistochemistry; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mifepristone; Neovascularization, Pathologic; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; Time Factors; Vascular Endothelial Growth Factors

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents; Carcinogens; Dexamethasone; Drug Administration Schedule; Drug Synergism; Extracellular Fluid; Female; Fluorouracil; Injections, Intraperitoneal; Mammary Neoplasms, Experimental; Neovascularization, Pathologic; Pressure; Rats; Rats, Sprague-Dawley

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinoma, Squamous Cell; Cricetinae; Female; Male; Mesocricetus; Mouth Mucosa; Mouth Neoplasms; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase Type II; Vascular Endothelial Growth Factor A

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Hyperbaric Oxygenation; Mammary Neoplasms, Experimental; Neovascularization, Pathologic; Oxygen; Rats; Rats, Sprague-Dawley

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Carbonic Anhydrases; Carcinogens; Carcinoma; Endothelial Cells; Female; Glucose Transporter Type 1; Glycolysis; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Mammary Neoplasms, Experimental; Neovascularization, Pathologic; Nitric Oxide Synthase Type II; Nuts; Plant Extracts; Rats; Rats, Sprague-Dawley; Semecarpus; Tumor Burden; Vascular Endothelial Growth Factor A

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Carcinogens; Catalase; Cell Proliferation; Cytochrome P-450 Enzyme System; Female; gamma-Glutamyltransferase; Glutathione; Glutathione Peroxidase; Glutathione Transferase; Immunohistochemistry; Lipid Peroxidation; Mammary Neoplasms, Experimental; Neovascularization, Pathologic; Oxidative Stress; Phenols; Random Allocation; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Tea; Xenobiotics

Topics: 9,10-Dimethyl-1,2-benzanthracene; Amino Acid Sequence; Animals; Base Sequence; Carcinogens; Carcinoma; Cocarcinogenesis; Female; Genes, ras; Genetic Predisposition to Disease; I-kappa B Kinase; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Mutation; Neovascularization, Pathologic; Papilloma; Skin Neoplasms; Tetradecanoylphorbol Acetate; Vascular Endothelial Growth Factor A

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents, Phytogenic; Female; Ginsenosides; Insulin-Like Growth Factor I; Mammary Neoplasms, Experimental; Mice; Microvessels; Neovascularization, Pathologic; Random Allocation; Vascular Endothelial Growth Factor A

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; B-Lymphocytes; Carcinoma, Squamous Cell; Cell Proliferation; Chemotaxis, Leukocyte; Cyclin-Dependent Kinase Inhibitor p16; Lymph Nodes; Lymphangiogenesis; Lymphatic Metastasis; Macrophages; Mice; Mice, Transgenic; Neovascularization, Pathologic; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Endostatins; Female; Gene Expression Regulation, Neoplastic; Immunohistochemistry; Lymphatic Metastasis; Male; Mice; Mice, Transgenic; Neovascularization, Pathologic; Skin Neoplasms

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Cell Line, Tumor; Cell Proliferation; Cytoprotection; Dermatitis, Contact; Female; Genetic Predisposition to Disease; Interleukin-12; Interleukin-23; Mice; Mice, Inbred C3H; Mice, Knockout; Neovascularization, Pathologic; Skin Neoplasms; Toll-Like Receptor 4

Topics: 9,10-Dimethyl-1,2-benzanthracene; Allantois; Animals; Carcinogens; Carcinoma, Squamous Cell; Chick Embryo; Cricetinae; Humans; Intercellular Signaling Peptides and Proteins; Male; Neovascularization, Pathologic; Nerve Tissue Proteins; Receptors, Immunologic; Roundabout Proteins; Signal Transduction; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; von Willebrand Factor

Topics: 9,10-Dimethyl-1,2-benzanthracene; Adjuvants, Immunologic; Animals; Antibodies, Monoclonal; Carcinogens; Carcinoma; Endothelium, Vascular; Female; Immunoconjugates; Immunoglobulin G; Injections, Intralesional; Injections, Intraperitoneal; Interleukin-2; Iodine Radioisotopes; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Neovascularization, Pathologic; Polysorbates; Rats; Receptor Protein-Tyrosine Kinases; Surface-Active Agents; Time Factors; Transplantation, Heterologous

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Transformation, Neoplastic; Cricetinae; Drug Screening Assays, Antitumor; Immunoenzyme Techniques; Male; Mesocricetus; Neoplasms, Experimental; Neovascularization, Pathologic; Transforming Growth Factor alpha; Vitamin E

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antioxidants; Cricetinae; Factor VIII; Glutathione; Immunohistochemistry; Male; Mesocricetus; Mouth Neoplasms; Neovascularization, Pathologic; Tumor Suppressor Protein p53

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Cells, Cultured; Cheek; Cricetinae; Gene Expression Regulation; Genes, ras; Keratinocytes; Male; Mesocricetus; Neovascularization, Pathologic; Phenotype; Transfection; Transforming Growth Factor beta

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; beta Carotene; Canthaxanthin; Carcinoma, Squamous Cell; Cheek; Cricetinae; Dose-Response Relationship, Drug; Factor VIII; Immunoenzyme Techniques; Isotretinoin; Male; Mesocricetus; Mouth Mucosa; Mouth Neoplasms; Neovascularization, Pathologic; Transforming Growth Factor alpha

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Centrosome; Disease Progression; Endothelial Growth Factors; Genes, p53; Humans; Lymphokines; Mice; Mice, Knockout; Neovascularization, Pathologic; Papilloma; Phenotype; Point Mutation; Skin Neoplasms; Tetradecanoylphorbol Acetate; Thrombospondin 1; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Carcinoma, Squamous Cell; Disease Models, Animal; Disease Progression; Mice; Mice, Inbred SENCAR; Neovascularization, Pathologic; Papilloma; Skin Neoplasms

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antibodies; Disease Models, Animal; Female; Image Processing, Computer-Assisted; Immunohistochemistry; Keratins; Mammary Neoplasms, Animal; Microcirculation; Microscopy, Confocal; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Staining and Labeling

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Disease Models, Animal; Endothelial Growth Factors; Female; Humans; Lymphokines; Mammary Neoplasms, Experimental; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cornea; Dose-Response Relationship, Drug; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Neovascularization, Pathologic; Progesterone; Rabbits; Rats; Rats, Sprague-Dawley; Time Factors

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Cell Adhesion Molecules; Cell Division; Disease Susceptibility; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Lymphokines; Mice; Mice, Inbred Strains; Mice, Knockout; Neovascularization, Pathologic; Oligodeoxyribonucleotides, Antisense; Papilloma; Precancerous Conditions; Skin; Skin Neoplasms; Thrombospondins; Time Factors; Transcription, Genetic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Benz(a)Anthracenes; Cheek; Cricetinae; Male; Mesocricetus; Mouth Neoplasms; Neovascularization, Pathologic

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Transformation, Neoplastic; Cells, Cultured; Cornea; Cricetinae; Female; Hybridomas; Keratinocytes; Male; Neovascularization, Pathologic; Phenotype; Rats; Suppression, Genetic

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Cheek; Cricetinae; Genes, Suppressor; Mouth Neoplasms; Neoplasms, Experimental; Neovascularization, Pathologic

Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inducing Agents; Animals; Cell Division; Chick Embryo; Culture Media; DNA; Mammary Neoplasms, Experimental; Mice; Neovascularization, Pathologic; Rabbits; Rats; Tumor Cells, Cultured

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Body Weight; Calcitriol; Calcium; Female; Mammary Neoplasms, Experimental; Neovascularization, Pathologic; Organ Size; Rats; Rats, Inbred Strains

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Separation; Cells, Cultured; Cheek; Cricetinae; Epithelium; Keratins; Mesocricetus; Microscopy, Phase-Contrast; Mouth Neoplasms; Neovascularization, Pathologic; Phenotype; Precancerous Conditions

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Autoradiography; Carcinoma, Squamous Cell; Cricetinae; Endothelium, Vascular; Female; Hydrocortisone; Immune Sera; Leukocyte Count; Macrophages; Male; Mesocricetus; Mouth Neoplasms; Neovascularization, Pathologic; Rabbits

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cells, Cultured; Drug Interactions; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Neovascularization, Pathologic; Rats; Rats, Inbred Strains

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Capillaries; Carcinoma, Squamous Cell; Cell Fusion; Cell Line; Cornea; Cricetinae; Epithelium; Female; Gene Expression Regulation; Hybrid Cells; Neoplasm Transplantation; Neovascularization, Pathologic; Rats; Rats, Inbred F344; Suppression, Genetic